French pharmaceutical company Sanofi (NASDAQ: SNY) has announced plans to invest EUR 1 billion (USD 1.05 billion) in the construction of a new manufacturing plant in the Beijing Economic-Technological Development Area. This marks the company’s largest investment in China to date.
Expanding Local Manufacturing Capacities for Insulin
The new facility will be Sanofi’s second factory in Beijing and its fourth in China. It is designed to enhance local, end-to-end manufacturing capabilities for insulin, addressing the specific treatment needs of local diabetes patients. This strategic expansion aligns with Sanofi’s commitment to improving access to diabetes care in China.-Fineline Info & Tech
